Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 2 recruiting now full pipeline small index

Eosinophilic Asthma: full-pipeline trial registry

2 of 5 indexed Eosinophilic Asthma trials are currently recruiting.

Corpus placement: #3,391 of 28,707 conditions by registered trial count.

5 US clinical trials · 2 currently recruiting · #3,391 of 28,707 conditions by registered trial count

Eosinophilic Asthma: 5 US clinical trials tracked, 2 recruiting.

Eosinophilic Asthma is the subject of 5 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 3 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is Knopp Biosciences, running 1 of these trials.

Enrollment posture brief

Registry condition eosinophilic-asthma

OPEN 2 | RECR 40% | LATE 3 | EARLY 2 | RANK #3391 | SPON 1

Nearest open-share peer: Achondroplasia (40% recruiting · 10 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Eosinophilic Asthma (this)40%
Open-enrollment share among volume-matched conditions near Eosinophilic Asthma

Eosinophilic Asthma lists 2 open slots (40% of 5 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Eosinophilic Asthma on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Eosinophilic Asthma is recruiting below its size-band peers.

    2 of 5 indexed trials (40%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Eosinophilic Asthma research.

    Knopp Biosciences accounts for 1 of 5 trials (20%). 5 distinct sponsors appear on at least one study for this condition label.

  3. Typical Eosinophilic Asthma enrolment sits around 489 participants.

    Median target enrolment is 489 among the 5 trials that report a genuine target (sentinel values excluded). 0 of those (0%) plan for fewer than 100 participants.

  4. Eosinophilic Asthma research is mostly interventional.

    5 interventional and 0 observational studies make up this index (100% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 22Phase 33

Phase Distribution

PhaseTrial count
Phase 2 2
Phase 3 3

Named interventions

Most-linked intervention names on Eosinophilic Asthma records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Placebo Drug
3 trials
Dexpramipexole Drug
1 trials
Reslizumab Drug
1 trials
Dexpramipexole Dihydrochloride Drug
1 trials
KT-621 Drug
1 trials
Placebo for Benralizumab Combination
1 trials
benralizumab Combination
1 trials
ICS-LABA Combination
1 trials

US sites by state

Facility locations filed on Eosinophilic Asthma trials. A trial with sites in several states counts in each.

California 5 trials
Florida 4 trials
Colorado 3 trials
Arizona 3 trials
Oklahoma 2 trials
New York 2 trials
Missouri 2 trials
Georgia 2 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Eosinophilic Asthma page

5 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 2 Eosinophilic Asthma trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • Knopp Biosciences sponsors the most Eosinophilic Asthma trials on record, review their full trial history before evaluating a specific study. See Knopp Biosciences's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Eosinophilic Asthma condition card totals 5 registered trials; most-linked intervention Placebo; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.